Management expressed positive long-term outlook for the sector and expressed confidence in Syngene's sustained performance on the back of improved fund flows into US biotech in the latter part of the year.
PureSoftware Technologies, with a paid-up capital of Rs 3.23 crores and a turnover of Rs 351 crores for fiscal 2024, will be acquired through an upfront cash consideration of Rs 635 crores.
A round-up of top newspaper stories to keep you ahead of others.
However, Chaba cautioned that the demand for EVs in India could remain subdued due to concerns about insufficient charging infrastructure. He emphasized the importance of addressing these infrastructure gaps.
Tesla highlighted the continued pressure on global EV sales, with many automakers prioritising hybrids over EVs. However, according to the company’s statement, Tesla remains committed to promoting EV adoption in line with its mission.
Maharashtra-based JNK India’s Rs 650 cr IPO has kicked off for subscription. The price band has been set at Rs 395-415 a share and the IPO will close on April 25. The IPO consists of fresh shares of Rs 300 crore and an offer-for-sale of up to 8.42 million shares by its existing shareholders and promoters. On the upper price band, the issue size will be Rs 650 crore and the post-issue market capitalisation is likely to be Rs 2,300 crore. The company has raised Rs 195 crore from institutional investors on April 22. Institutional investors including Goldman Sachs, Allianz Global Investors Fund, Natixis International Funds, Kotak Mutual Fund, HDFC Mutual Fund, Nippon Life India, Mirae, DSP Mutual Fund, Edelweiss Trusteeship, LIC Mutual Fund, Bajaj Allianz Life Insurance Company and Aditya Birla Sun Life Insurance Company invested in the company via anchor book. Catch Nandita Khemka in conversation with Arvind Kamath, Chairperson and Goutam Rampelli, Director of the company.
A round-up of top newspaper stories to keep you ahead of others.
After witnessing a sharp recovery on Friday, Nifty could trade in a range ahead of April series expiry this week. Divergent cues could keep investors on edge as Geo political tensions and elections are factors that could be at play. Big corporate earnings like RIL, HUL expected this week. Moneycontrol’s Stacy pereira discussed all this with Kunal Rambhia—Fund Manager, The Streets and Kranthi Bathini, Equity strategist at WealthMills securities on Opening Bell
In his expanded role, Saigal will further strengthen the bank’s relationship with its top clients and will be responsible for driving further growth and synergies in our market leading M&A and Financing businesses, the bank said.
Wipro Management On Wipro Q4 Earnings & Future Outlook. Watch the presser live on Moneycontrol to know more.
BSE Sensex was up by 0.76% or 550 points to 73,041.27 while NSE Nifty was at 22,142 up by 0.65% or 142 points A total of 3,890 stocks were actively traded, 1,698 advanced, 2,071 declined and 121 stocks remained unchanged. 171 stocks hit 52 week high and 19 stocks hit 52 week low on the BSE. Catch Yatin Mota and Santosh Nair as they discuss stocks on their radar including Bajaj AUto and Infosys
The collaboration will enhance Padget Electronics' offerings in the global smartphone market, Dixon has said
Infosys On Q4 Earnings & Future Outlook. Watch the Presser live on Moneycontrol to know more.
Vodafone Idea’s mega Rs 18,000 cr FPO opens for subscription. The company has raised Rs 5,400 crore from 74 anchor investors, the company announced in a press statement on Wednesday. The investors include GQG Partners, The Master Trust Bank of Japan, UBS, Morgan Stanley Investment Management, Citigroup Global Markets, Australian Super, Fidelity, Quant, and Motilal Oswal. In an interview to Moneycontrol’s Nandita Khemka, CEO Akshay Mundra highlights the company's strategy to address subscriber loss by prioritising 4G coverage and capacity growth. Despite challenges, including a significant portion of 2G subscribers, Vodafone Idea aims to align ARPU growth with industry peers.
Third day of selloff; Nifty drops below 22,200. Sensex drops below 73,000; India VIX rises further Broader markets outperform benchmarks. Breadth in favour of gainers; NSE advance-decline ratio at 2:1 .Nifty Bank below 47,500; IT top laggard. PSU Banks, metals among sectoral losers. Catch Nandita Khemka and Yatin Mota as they discuss stocks on their radar including Exide and Bharti Hexacom
Vashistha, a chartered accountant, joined Citi as head of equity capital markets in November 2014 from UBS
Nifty snaps record run; index skids over 200 points .Benchmarks underperform broader markets Breadth weak; advance-decline ratio at 1:2. All sectors in the red led by pharma, FMCG & IT. Catch Yatin Mota and Nandita Khemka as they discuss stocks on their radar including TCS and Entero Healthcare
Lupin recalled 26,352 bottles of Rifampin capsules, used in the treatment of tuberculosis
Indian equity markets saw a strong start to the week with the benchmarks conquering new highs.Investors seem hopeful for further rally towards 22,800 level on the Nifty 50. ON wall street stocks traded rather flat, while asian markets are poised for a positive start given the jump in U.S. Treasury yields. Among stocks in focus will be Axis Bank, Gland pharma on reports of likely block deals, Tata Motors & Eicher motors will be in focus as well as stocks like Dixon tech in the midcap space. Moneycontrol's Stacy Pereira speaks with Kunal Rambhia, Fund Manager, The Streets and Rishi Kohli, Managing Partner & CIO, Hedge Fund Strategies, InCred Alternative Investments on Opening Bell.
While most of the corporates have shown double digit value growth, unit growth remains a challenge for the Indian pharma market, according to analysts
Global Silver prices at 3-year high near $28/oz . Prices in India at all time high near Rs 82,000/kg. Silver takes support from record gold levels. -1/3rd supply consumed by solar industry. Manisha Gupta tells more about it
The strategic investment will fuel Biodeal's development of innovative solutions, enhance its production capabilities with advanced technology, and expand operations, positioning it as a leading nasal spray manufacturer
The central bank expects increased rural activity and consistent urban demand to boost consumption
General Atlantic's former investments in India in the sector include Rubicon Research, ASG Eyecare and Hyderabad's KIMS Hospitals.